Hand Foot Syndrome Secondary to Low Dose Docetaxel

Mutahir A Tunio; Mushabbab Al Asiri; Sajid Khan Durrani

View/Download PDF

Buy Reprints

PDF

Translate this page into:

Original Article

9 (

); 336-337

Hand Foot Syndrome Secondary to Low Dose Docetaxel

Mutahir A Tunio, Mushabbab Al Asiri, Sajid Khan Durrani

Received: 2015-04-01, Accepted: 2015-06-22, Published: 2015-10-02

Licence

This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

Disclaimer:
This article was originally published by Qassim University and was migrated to Scientific Scholar after the change of Publisher.

Abstract

Hand-foot syndrome (palmoplantar erythrodysesthesia or Burgdorf reaction), is a distinctive skin toxicity affecting the palms and soles after certain chemotherapeutic drugs. Docetaxel induced hand-foot syndrome is rare, dose-dependent adverse event. Here in we report a case of Docetaxel induced grade III hand-foot syndrome at low doses (75/m2).